Article Text

Download PDFPDF
Concise report
A 78-joints ultrasonographic assessment is associated with clinical assessments and is highly responsive to improvement in a longitudinal study of patients with rheumatoid arthritis starting adalimumab treatment
  1. Hilde Berner Hammer,
  2. Margareth Sveinsson,
  3. Anne Katrine Kongtorp,
  4. Tore K Kvien
  1. Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
  1. Correspondence to Dr Hilde Berner Hammer, Department of Rheumatology, Diakonhjemmet Hospital, Box 23, Vinderen, N-0319 Oslo, Norway; hbham{at}


Objectives To examine associations between ultrasonography (US) assessments (B-mode (BM) and power Doppler (PD)) of a large number of joints and traditional assessments of disease activity, and to examine the sensitivity to change of the US scores and clinical measures in patients with rheumatoid arthritis (RA).

Methods Twenty patients with RA initiating adalimumab treatment were examined at baseline and after 1, 3, 6 and 12 months with US (BM and PD) using an Outcome Measures in Rheumatoid Arthritis Clinical Trial semiquantitative scoring (0–3) of 78 joints as well as assessment of clinical and laboratory variables with calculation of composite indexes.

Results The US scores were associated with composite scores as well as clinical and laboratory variables (r=0.41–0.84, p<0.05–0.001 at 12-months' follow-up). Compared with clinical assessments, US detected higher numbers of inflamed joints. The US scores decreased after 1 and 3 months (p<0.005) and PD showed the highest percentage improvement. Both BM and PD had high standardised response means throughout the study (−0.83 to −1.27), of similar magnitude to composite indexes, but higher than the clinical and laboratory variables.

Conclusions The comprehensive US assessments were associated with clinical and laboratory variables of disease activity and were highly sensitive to change during treatment with biological agents.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding HBH was partly supported by an unrestricted grant from Abbott.

  • Competing interests Johannes WJ Bijlsma was the handling editor for this article

  • Ethics approval This study was conducted with the approval of Regional Committee for Medical and Health Research Ethics (REK), South-East.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent Obtained.